Outcomes by Gender in the African-American Heart Failure Trial

Journal of the American College of Cardiology

Volumn 48, Issue 11, 2006, Pages 2263-2267

  Taylor, Anne L ^a   Lindenfeld, JoAnn ^b   Ziesche, Susan ^c   Walsh, Mary Norine ^d   Mitchell, Judith E ^e   Adams, Kirkwood ^f   Tam, S William ^g   Ofili, Elizabeth ^h   Sabolinski, Michael L ^g   Worcel, Manuel ^g   Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Care Group   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g NitroMed Inc   (United States)

^h MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; PLACEBO; SPIRONOLACTONE;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE FREE SURVIVAL; DIZZINESS; DRUG INDUCED HEADACHE; FEMALE; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INDUCED HYPOTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; AGED; CARDIAC OUTPUT, LOW; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; HYDRALAZINE; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 33845224837     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.020     Document Type: Article

References (12)

1. Lindenfeld J., Krause-Steinrauf H., and Salerno J. Where are all the women with heart failure?. J Am Coll Cardiol 30 (1997) 1417-1419
2. Heiat A., Gross C.P., and Krumholz H.M. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162 (2002) 1682-1688
3. Petrie M.C., Dawson N.P., Murdoch D.R., Davie A.P., and McMurray J.J.V. Failure of women's hearts. Circulation 99 (1999) 2334-2341
4. Cohn J.N., Archibald D.G., Ziesche S., et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure, results of a Veterans Administration Cooperative Study. N Engl J Med 314 (1986) 1547-1552
5. Cohn J.N., Johnson C., Ziesche S., et al. A comparison of enalapril with that of hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 (1991) 303-310
6. Carson P., Ziesche S., Johnson C., Cohn J.N., and Vasodilator Heart Failure Trial Study Group. Racial differences in response to therapy for heart failure: analysis of the vasodilator heart failure trials. J Card Fail 5 (1999) 178-187
7. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057
8. Yancy C.W. Heart failure in African-Americans: a cardiovascular enigma. J Card Fail 6 (2000) 183-186
9. Shekelle P.G., Rich M.W., Morton S.C., et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 41 (2003) 1529-1538
10. Exner D.V., Dries D.L., Domanski M.J., and Cohn J.N. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared to white patients with left ventricular dysfunction. N Engl J Med 344 (2004) 1351-1357
11. Dries D.L., Exner D.V., Gersh B.J., Cooper H.A., Carson P.E., and Domanski M.J. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 340 (1999) 609-616
12. Taylor A.L., Wright J.T., Cooper R.S., and Psaty B.M. Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Circulation 112 (2005) 3654-3666